169259 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing; Immunoassay; Biospecific binding assay; Materials therefor for cancer; Specifically defined cancers of cervix
SYNTHESIS AND COMPOSITION OF AMINO ACID LINKING GROUPS CONJUGATED TO COMPOUNDS USED FOR THE TARGETED IMAGING OF TUMORS
#2TREATING METHOD
#3METHOD FOR DETECTING AND ISOLATING CELL POPULATION CO-EXPRESSING CD45 AND EPCAM AND USE THEREOF
#4SCREENING SYSTEMS AND METHODS FOR HPV-ASSOCIATED CERVICAL DISEASE
#5ANTIBODIES AND ASSAYS FOR DETECTION OF FOLATE RECEPTOR 1
#6BIOLOGIC FOR THE TREATMENT OF CANCER
#7METHODS OF DIAGNOSING AND TREATING CERVICAL CANCER
#8MACHINE LEARNING-BASED ASN GROUPING FOR PREDICTING CERVICAL CANCER PROGNOSIS AND CHEMORADIOTHERAPY RESPONSE USING ATP5H, SCP3, AND NANOG
#9Biomarkers for Detecting Cancer
#10DEVICES, SYSTEMS, AND METHODS FOR THE DETECTION OF A TARGET ANALYTE USING MAGNETIC FOCUS LATERAL FLOW IMMUNOASSAY TECHNIQUES
#11KERATINS AS BIOMARKERS FOR CERVICAL CANCER AND SURVIVAL
#12Methods of treating gastrointestinal diseases characterized by inflammatory cells
#13CRISPR ASSAY FOR RAPID, ENHANCED SCREENING OF HPV-RELATED DISEASE
#14Compound or salt thereof, composition for cysteine detection, fluorescent probe and composition for diagnosing cancer containing the same, method for detecting cysteine, method for providing information for diagnosing cancer, and method for producing compound
#15SYNTHESIS AND COMPOSITION OF AMINO ACID LINKING GROUPS CONJUGATED TO COMPOUNDS USED FOR THE TARGETED IMAGING OF TUMORS
#16METHODS FOR MONITORING OR PREDICTING RESPONSE TO IMMUNOTHERAPIES FOR GYNECOLOGIC CANCER
#17Method for increasing the efficacy of cancer therapy by administering an anti-FOLR1 immunoconjugate
#18PROPHYLAXIS AND TREATMENT OF AN INFECTION OF THE CERVIX WITH HUMAN PAPILLOMAVIRUS (HPV)
#19BIOMARKERS FOR DETERMINING SURVIVAL AND THERAPEUTIC RESPONSE IN CERVICAL CANCER
#20USE OF MCM5 AS A MARKER FOR GYNAECOLOGICAL CANCERS
#21Screening kit for detection of grades of cervical cancer and process for the preparation thereof
#22SCREENING SYSTEMS AND METHODS FOR HPV-ASSOCIATED CERVICAL DISEASE
#23CERVICAL CANCER ORGANOIDS
#24Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors
#25METHODS OF DETERMINING INTERFERON HAVING DIRECT INHIBITORY EFFECTS ON TUMORS AND USES THEREOF
#26PHARMACEUTICAL USE OF ACTININ-4 INVOLVED IN INDUCTION OF CERVICAL CANCER
#27Synthesis and composition of non-amino acid linking groups conjugated to compounds used for the targeted imaging of tumors
#28Portable diffraction-based imaging and diagnostic systems and methods
#29Biologic for the treatment of cancer
#30METHOD FOR IMPROVED DIAGNOSIS OF DYSPLASIAS
#31METHOD FOR IMPROVED DIAGNOSIS OF DYSPLASIAS
#32METHODS AND APPARATUS FOR IDENTIFYING DISEASE STATUS USING BIOMARKERS
#33Methods of diagnosing and treating cervical cancer
#34APPLICATION OF APTAMER IN RECOGNITION AND BINDING OF ALKALINE PHOSPHATASE HETERODIMER OR TUMOR DETECTION
#35Method for identifying an ovarian cancer in a subject likely to respond to anti-folate receptor 1 (FOLR1) antibody
#36COMPOSITIONS AND METHODS OF USE FOR DETERMINATION OF HE4a
#37Saccharide-based biomarkers and therapeutics
#38Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors
#39Devices, systems, and methods for the detection of a target analyte using magnetic focus lateral flow immunoassay techniques
#40Method for identification of low grade cervical cytology cases likely to progress to high grade/cancer
#41Method of Assessing Risk
#42METHOD FOR IMPROVED DIAGNOSIS OF DYSPLASIAS
#43Method for discrimination of metaplasias from neoplastic or preneoplastic lesions
#44METHODS AND COMPOSITIONS FOR DETECTING ENDOMETRIAL OR OVARIAN CANCER
#45Portable diffraction-based imaging and diagnostic systems and methods
#46Method for the normalization of immunological tests and kits for performing such tests
#47Methods of using antibodies to detect folate receptor 1 (FOLR1)
#48Materials and methods for detecting cancer based on urinary levels of RHAMM
#49Flourescent exomarker probes for hydrogen sulfide detection
#50CERVICAL CANCER TESTING METHOD AND TEST REAGENT USED THEREFOR
#51IMMUNOLOGICAL TEST FOR THE DETECTION OF E7 ONCOPROTEINS IN BIOLOGICAL SAMPLES
#52“Immune checkpoint intervention” in cancer
#53Cancer Detection Method
#54PHARMACEUTICAL USE OF ACTININ-4 INVOLVED IN INDUCTION OF CERVICAL CANCER
#55Fusion molecule based on TAA variant
#56Anti-GPNMB antibodies and diagnostic uses thereof
#57Method of treating cervical neoplasia in patients infected with human papilloma virus
#58Methods of determining interferon having direct inhibitory effects on tumors and uses thereof
#59Cancer screening by detection of ultrastructural and molecular markers
#60Method of predicting effect of treatment by PD-1/PD-L1 blockade using abnormality of PD-L1 (CD274) as index
#61Methods used to treat cancer
#62KERATINS AS BIOMARKERS FOR CERVICAL CANCER AND SURVIVAL
#63COMPOSITIONS AND METHODS OF USE FOR DETERMINATION OF HE4a
#64MULTIPLEXED IMMUNOHISTOCHEMISTRY ASSAYS FOR DIAGNOSIS AND TREATMENT OF CANCER
#65Methods of treating cancer in a patient by administering anti-folate-receptor-1 (FOLR1) antibodies
#66Microplate and in vitro diagnostic kit for HPV 16/E7 oncoprotein detection and preparation method thereof
#67Method for discrimination of metaplasias from neoplastic or preneoplastic lesions
#68Saccharide-based biomarkers and therapeutics
#69ANTI-GRPR ANTIBODY, METHOD FOR PRODUCING SAME, DETECTION METHOD, USE OF THE ANTIBODY, KIT AND GENE CONSTRUCT
#70HPV16 Antibodies as Diagnostic and Prognostic Biomarkers in Pre-Invasive and Invasive Disease
#71Device for high throughput detection of cervical disease
#72Methods and Systems for Predicting Whether a Subject Has a Cervical Intraepithelial Neoplasia (CIN) Lesion from a Suspension Sample of Cervical Cells
#73Fusion molecule based on novel TAA variant
#74METHOD FOR DETECTING CARCINOGENESIS IN THE UTERINE CERVIX
#75NOVEL METHODS, BIOASSAYS, AND BIOMARKERS FOR HPV-RELATED CONDITIONS
#76Methods for detecting and treating cancer
#77METHOD OF EVALUATING FEMALE GENITAL CANCER
#78Methods of using propentofylline to treat glioma and glioblastoma
#79Portable diffraction-based imaging and diagnostic systems and methods
#80KERATINS AS BIOMARKERS FOR CERVICAL CANCER AND SURVIVAL
#81Monoclonal antibody recognizing human papillomavirus (HPV) L2 protein and method for measuring HPV-neutralizing antibody titer using the same
#82Aptamers and use of the aptamers in the diagnosis and treatment of cancer
#83BIOMARKERS FOR CERVICAL CANCER
#84COMPOSITION FOR DETECTION OR DIAGNOSIS OF DISEASES CONTAINING TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR
#85Systems And Methods For Early Detection Of Cervical Cancer By Multiplex Protein Biomarkers
#86Compositions and methods of use for determination of HE4a
#87Cancer screening by detection of ultrastructural and molecular markers
#88Cancer marker and utilization thereof
#89Methods and systems for predicting whether a subject has a cervical intraepithelial neoplasia (CIN) lesion from a suspension sample of cervical cells
#90Methods and compositions for detecting endometrial or ovarian cancer
#91Biomarkers for subtypes of cervical cancer
#92METHOD FOR IDENTIFYING MARKER SEQUENCES FOR GYNAECOLOGICAL MALIGNANT TUMOURS
#93Antibodies for oncogenic strains of HPV and methods of their use
#94Monoclonal antibodies for detection of folate receptor 1
#95Method for detecting cervical dysplasia
#96Methods and biomarkers for detection and prognosis of cervical cancer
#97Sample vial for digital holographic analysis of a liquid cell sample
#98Liquid medium and sample vial for use in a method for detecting cancerous cells in a cell sample
#99Method for discrimination of metaplasias from neoplastic or preneoplastic lesions
#100Cancer screening by detection of ultrastructural and molecular markers
#101Compositions and methods for detection and treatment of cancer
#102Methods used in sensitizing invasive glioblastoma to therapeutic treatment
#103DIAGNOSTIC MARKERS FOR DETERMINING THE PREDISPOSITION TO THE DEVELOPMENT OF CERVICAL CANCER AND OLIGONUCLEOTIDES USED FOR THE DETERMINATION
#104Monoclonal antibody recognizing human papillomavirus (HPV) L2 protein and method for measuring HPV-neutralizing antibody titer using the same
#105Fusion molecule based on novel TAA variant
#106Method for improved diagnosis of dysplasias
#107METHODS AND APPARATUS FOR IDENTIFYING DISEASE STATUS USING BIOMARKERS
#108PLA2ACTIVITY AS A MARKER FOR OVARIAN AND OTHER GYNECOLOGIC CANCERS
#109CERVICAL CANCER SCREENING BY MOLECULAR DETECTION OF HUMAN PAPILLOMAVIRUS-INDUCED NEOPLASIA
#110Methods and compositions for detecting endometrial or ovarian cancer
#111High throughput cell-based HPV immunoassays for diagnosis and screening of HPV-associated cancers
#112COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF CERVICAL CANCER
#113AUTOMATED PAP SCREENING USING A PLURALITY OF BIOMARKERS AND MULTI-SPECTRAL IMAGING
#114Cancer screening by detection of ultrastructural and molecular markers
#115H3K27me3 and Cancer
#116Antibodies For Oncogenic Strains Of HPV And Methods Of Their Use
#117Flap Endonuclease-1 As A Marker For Cancer
#118Device and methods for the detection of cervical disease
#119DIAGNOSTIC MARKERS FOR DETERMINING THE PREDISPOSITION TO THE DEVELOPMENT OF CERVICAL CANCER AND OLIGONUCLEOTIDES USED FOR THE DETERMINATION
#120Methods and systems for predicting whether a subject has a cervical intraepithelial neoplasia (CIN) lesion from a suspension sample of cervical cells
#121TSLP PROMOTES IMMUNE EVASION AND PERSISTENCE OF VIRUSES
#122CIP2A as a biomarker in detection of cervical cancer
#123Kits for and methods of differential staining of cervical cancer cells and/or tissues
#124Method for discrimination of metaplasias from neoplastic or preneoplastic lesions
#125Identification of high grade or ≧ CIN2 for early stages and late stages detection, screening, and diagnosis of human papillomavirus (HPV) and HPV-associated cancers
#126METHODS OF DIAGNOSING CERVICAL CANCER
#127Methods and kit for detecting breast cancer
#128MCM6 and MCM7 monoclonal antibodies and methods for their use in the detection of cervical disease
#129Novel Method of Diagnosing, Monitoring, Staging, Imaging and Treating Various Cancers
#130Methods used in identifying glioblastoma
#131METHODS FOR PREDICTING CANCER RESPONSE TO EGFR INHIBITORS
#132Methods for detecting and treating cancer
#133METHODS AND KITS USED IN IDENTIFYING GLIOBLASTOMA
#134Biomarkers for subtypes of cervical cancer
#135Neoepitope detection of disease using protein arrays
#136CERVICAL SCREENING ALGORITHMS
#137COMPOSITIONS AND METHODS FOR DETECTING AND TREATING DISEASES AND CONDITIONS RELATED TO CHEMOKINE RECEPTORS
#138METHOD OF EVALUATING FEMALE GENITAL CANCER
#139MARKER FOR ESTIMATING THE DIAGNOSIS OF CERVICAL ADENOCARCINOMA OR FOR ESTIMATING THE PROGNOSIS OF CERVICAL CANCER
#140REAGENT FOR DETECTING ABNORMAL CELL IN CERVIX OF UTERUS, AND METHOD FOR DETECTING ABNORMAL CELL IN CERVIX OF UTERUS BY USING SAME
#141Cell dispersion method, cell dispersing agent and cell measurement method
#142Compositions and methods for detecting cancer
#143Compositions and Methods to Inhibit HPV Infection
#144METHODS AND APPARATUS FOR IDENTIFYING DISEASE STATUS USING BIOMARKERS
#145PRESENT INVENTION RELATES TO METHODS FOR PREDICTION OF THE THERAPEUTIC SUCCESS OF BREAST CANCER THERAPY
#146Biomarkers for HPV-Induced Cancer
#147Method of diagnosing, monitoring, staging, imaging and treating various cancers
#148COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF LUNG CANCER
#149Antibodies for oncogenic strains of HPV and methods of their use
#150Fusion molecule based on novel TAA variant
#151DIAGNOSIS AND TREATMENT OF CERVICAL CANCER
#152Epigenetic silencing of tumor suppressor genes
#153Method for Diagnosing Tumors by Measuring the Level of Apolipoprotein A-IV
#154METHODS AND COMPOSITIONS FOR TREATING CERVICAL CANCER
#155DIAGNOSTIC AGENT FOR TUMOR
#156CTIP2 expression in squamous cell carcinoma
#157Monoclonal antibodies and methods for their use in the detection of cervical disease
#158Proteomic Methods For The Identification And Use Of Putative Biomarkers Associated With The Dysplastic State In Cervical Cells Or Other Cell Types
#159KITS FOR DETECTING CERVICAL DYSPLASIA
#160Method for improved diagnosis of dysplasias
#161METHODS AND COMPOSITIONS FOR THE DETECTION OF CERVICAL DISEASE
#162Method for discrimination of metaplasias from neoplastic or preneoplastic lesions
#163Advanced cervical cell screening methods
#164METHODS AND COMPOSITIONS FOR THE DETECTION OF CERVICAL DISEASE
#165Methods for improved diagnosis of dysplasias
#166Compositions and methods for the therapy and diagnosis of lung cancer
#167Antibodies for oncogenic strains of HPV and methods of their use
#168Compositions and methods for detecting cancer
#169MCM6 and MCM7 monoclonal antibodies and methods for their use in the detection of cervical disease
#170Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
#171Na, K-ATPase expression in cervical dysplasia and cancer
#172Methods of detecting ovarian cancer
#173Method and devices for screening cervical cancer
#174Methods of diagnosing cervical cancer
#175Diagnosis and treatment of cervical cancer
#176Antibodies That Immunospecifically Bind to TRAIL Receptors
#177METHODS AND APPARATUS FOR IDENTIFYING DISEASE STATUS USING BIOMARKERS
#178METHODS AND APPARATUS FOR IDENTIFYING DISEASE STATUS USING BIOMARKERS
#179Method for detecting neoplastic disorders in a solubilized body sample
#180MCM6 and MCM7 monoclonal antibodies and methods for their use in the detection of cervical disease
#181Compositions and methods for the therapy and diagnosis of lung cancer
#182Diagnostic reagent for uterine adenocarcinoma and method of detecting adenocarcinoma cells
#183Systems of diagnosing cervical cancer
#184Method for improved diagnosis of dysplasias
#185Method of treating cells
#186Monoclonal antibodies and methods for their use in the detection of cervical disease
#187Methods and compositions for treating cervical cancer
#188Diagnosis and treatment of cervical cancer
#189Method for prognostic evaluation of carcinoma using anti-P-LAP antibody
#190DIAGNOSING AND TREATING CANCER
#191Methods and compositions for the detection of cervical disease
#192Methods and compositions for the detection of cervical disease
#193Novel diagnosis & treatment tools for cancer using the NRIP antibody and RNA interference
#194Monoclonal antibodies and methods for their use in the detection of cervical disease
#195Method for detecting carcinomas in a solubilized cervical body sample
#196Regulated genes in cervical cancer
#197Compounds and methods of early diagnosis of cervical cancer and genital condyloma with HPV, CHSP60 tumor suppressor H-Ras, K-Ras and PTEN derived peptides modified
#198Erk7 and erk8, novel diagnostic markers for cancer
#199Peptides from the E2 proteins of human papillomaviruses 16 and 18 for detecting and/or diagnosing cervical and other human papillomavirus associated cancers
#200Methods and compositions for the detection of cervical disease
#201Method for discrimination of metaplasias from neoplastic or preneoplastic lesions
#202Methods of diagnosing cervical cancer
#203Neoepitope detection of disease using protein arrays
#204Method for screening cervical cancer
#205Peptides from the E7 protein of human papilloma viruses 16 and 18 for detecting and/or diagnosing cervical and other human papilloma virus associated cancers
#206Novel human genes and methods of use thereof
#207Diagnosing and treating cancer
#208Methods and compositions for the detection of cervical cancer
#209Method for manufacturing a layer lamination integrated fuel cell and the fuel cell itself
#210Novel method of diagnosing, monitoring, staging, imaging and treating various cancers
#211Novel method of diagnosing, monitoring, staging, imaging and treating various cancers
#212Methods for the detection of cervical cancer
#213Antibodies for oncogenic strains of HPV and methods of their use
#214Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
#215Laminin chains: diagnostic and therapeutic use
#216Methods for determining risk of developing cervical cancer
#217Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer